Increasing chronic diseases further create growth opportunity in the Indian life science instrumentation market

Published: May 2021

Indian life science instrumentation market is projected to grow at a significant CAGR of around 6.5% during the forecast period (2021-2027). The rise in chronic diseases such as cancer, CVD, and others in the country further creating the scope for the various research activities in the country that further projected to provide ample opportunity to the life science instrumentation market. Cancer cases in India have almost doubled in over a few decades. The major five types of cancers in men are lip/oral cavity, lung cancer, stomach cancer, colorectum cancer, and pharynx cancer, whereas the top five types of cancer in women are breast cancer, cervix cancer, colorectum cancer, ovary cancer, and lip/oral cancer. Colorectum is the fourth major disease affecting men and third among women in India. 

Browse the full report description of "Indian Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals &Laboratories) and Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/indian-life-science-instrumentation-market

In addition to colorectal cancer, CVD prevalence in the country is further likely to increase the research activities in the country that further influence the use of life science instrumentation and further contribute to the market growth. The increasing prevalence of CVDs in the country is driving the need for advanced therapies such as cell harvesting, cell culture, next-generation sequencing, and others. Cell harvesting techniques are rapidly being adopted for the treatment of cardiac diseases that further require life science instrumentation such as clinical chemistry analyzers, immunoassays, and others that further create significant growth in the market.

Market Coverage

Report Elements

Details

Study Period

2020-2027

Base year

2020

Forecast period

2021-2027

Segments Covered

By Technology and by End-User

Key Companies Profiled

Danaher Corp., General Electric Co., Hitachi High-Tech Corp., HORIBA, Ltd, Shimadzu Corp., Thermo Fisher Scientific, Inc., and others


Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • How will COVID-19 impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Indian Life Science Instrumentation Market – Segmentation

By Technology

  • Chromatography
  • Spectroscopy
  • Polymerase Chain Reaction (PCR)
  • Clinical Chemistry Analyzers
  • Immunoassays
  • Next-Generation Sequencing (NGS)
  • Flow Cytometry
  • Microscopy 
  • Others (Centrifuges, Electrophoresis)

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes 
  • Hospitals and Laboratories 

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/indian-life-science-instrumentation-market